Team seeks to shed light on rare immune-mediated adverse drug reaction

Thirty years ago when she was 16, Katie Niemeyer was prescribed carbamazepine for depression. Three weeks later she was in a St. Louis, Missouri, burn unit with second and third degree burns all over her body. “My parents were told the chances of me surviving were slim,” she said.

New research finds lung cancer risk drops substantially within five years of quitting smoking

Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer.  That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.

Alphavirus “Achilles heel”

Targeting the protein that mosquito-borne viruses use to enter cells could be a strategy for preventing infection by multiple emerging viruses.

Honoring Robertson

David Robertson, MD, second from left, poses with three longtime colleagues who spoke during last week’s symposium honoring his scientific legacy.

Vanderbilt plays major role in nationwide “All of Us” research program — press release

New breast cancer targets

A special genetic analysis has revealed candidate genes associated with increased risk of breast cancer.